Select Medical Q4 Earnings Miss Estimates on Increasing Expenses
SEM posts a Q4 EPS miss as rising expenses and margin pressure weigh on results despite revenue growth and strength in key segments.
Select Medical (SEM) Q4 Earnings Miss Estimates
Select Medical (SEM) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.18 per share a year ago.
SEM to Report Q4 Earnings: Can Higher Admissions Protect Results?
Select Medical heads into Q4 earnings with EPS expected to be up 27.8% and revenues rising 3.7%, as key segments show growth.
Select Medical Expands Rehab Footprint Through Vibra Healthcare JV
SEM teams up with Vibra Healthcare to run a 76-bed rehab hospital in Southern Kentucky, expanding its post-acute care footprint through a capital-efficient JV.
Are Investors Undervaluing Select Medical (SEM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Select Medical (SEM) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Select Medical (SEM) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Despite Fast-paced Momentum, Select Medical (SEM) Is Still a Bargain Stock
Select Medical (SEM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Here's Why Select Medical (SEM) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Take SEM Off the Menu? Executive Chairman Gives Premium Offer
Select Medical draws investor focus as its executive chairman offers a take-private idea at up to a 15.6% premium to the latest close.
Should Value Investors Buy Select Medical (SEM) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical Down 5% Despite Q3 Earnings Beat on Patient Volumes
SEM's Q3 earnings drop 11.5% year over year due to the rising cost of services, despite a revenue beat and raised 2025 EPS guidance.
